Magnetic resonance with stimulation
AssigneeThe McLean Hospital Corporation
InventorsRonald Cowan, Perry Renshaw, Blaise Frederick, Scott Lukas
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe McLean Hospital Corporation
InventorsRonald Cowan, Perry Renshaw, Blaise Frederick, Scott Lukas
Estimating the term…
This invention involves blood oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI) using external stimuli. Different colors of light can be used as the stimulus to assess differential BOLD response to diagnose neurological disorders (e.g., Parkinson's disease, attention deficit disorder, schizophrenia, and substance abuse). In addition, very low dose administration of a drug that affects intracerebral vasculature can enhance BOLD response, facilitating detection and improving diagnostic capabilities. Using a very low dose of d-amphetamine, BOLD response to blue light is increased.
A method of diagnosing altered dopaminergic function based at least in part on a subject's blood oxygen level dependent responses comprising:
A method of enhancing contrast in functional magnetic resonance imaging by increasing blood oxygen level dependent response to a stimulus, the method comprising:
A method of magnetic resonance imaging to measure blood oxygen level dependent responses of a subject to light having at least two wavelengths:
Dependencies are inferred from the claim text.